Mpox (Set 1 in English): Understanding Mpox - The Virus, Stigma, and Public Health
Podcasts by SANGYAN for Public Health FAQs and Education
Release Date: 10/31/2024
Podcasts by SANGYAN for Public Health FAQs and Education
कैसे दुनिया मिलकर एएमआर से लड़ रही है Sangyan Podcast के इस एपिसोड में आपका स्वागत है! आज हम चर्चा करेंगे कि दुनिया भर में एंटीमाइक्रोबियल रेजिस्टेंस (AMR) से निपटने के लिए कैसे मिलकर काम किया जा रहा है और विशेष रूप से भारत में इस बढ़ते...
info_outline Antimicrobial Resistance (Set 6 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
हम क्या कर सकते हैं – कुछ आसान कदम Sangyan Podcast के एक और एपिसोड में आपका स्वागत है! आज हम कुछ आसान कदमों पर चर्चा करेंगे, जिनका पालन करके हम सभी एंटीमाइक्रोबियल रेजिस्टेंस (AMR) से लड़ने में मदद कर सकते हैं और यह सुनिश्चित कर सकते हैं कि...
info_outline Antimicrobial Resistance (Set 5 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
अस्पताल और घरों में एएमआर से बचने के आसान तरीके Sangyan Podcast में एक बार फिर से आपका स्वागत है! आज के एपिसोड में हम कुछ आसान और कारगर तरीकों पर बात करेंगे, जिनसे हम एंटीमाइक्रोबियल रेजिस्टेंस (AMR) से बच सकते हैं, चाहे हम घर पर हों या अस्पताल...
info_outline Antimicrobial Resistance (Set 4 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
खाने में एंटीबायोटिक्स का इस्तेमाल और इसका हमारे स्वास्थ्य पर असर आप सभी का स्वागत है Sangyan Podcast में! आज के एपिसोड में हम एक महत्वपूर्ण मुद्दे पर बात करेंगे—खाद्य उत्पादन में एंटीबायोटिक्स की भूमिका और इसका हमारे स्वास्थ्य पर असर।...
info_outline Antimicrobial Resistance (Set 3 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
एएमआर का हमारी सेहत और सुरक्षा पर असर होस्ट: नमस्कार! स्वागत है आप सभी का Sangyan Podcast के आज के एपिसोड में। मैं हूं आपकी होस्ट, साक्षी। आज हम बात करेंगे कि एंटीमाइक्रोबियल रेजिस्टेंस (AMR) कैसे हमारी सेहत को प्रभावित कर रहा है और साधारण से...
info_outline Antimicrobial Resistance (Set 2 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
एएमआर कैसे बढ़ता है – हमारी गलतियों से बढ़ती समस्या Sakshi (Host): नमस्ते और स्वागत है आपका Sangyan Podcast के आज के एपिसोड में। मैं आपकी होस्ट, साक्षी। आज हम बात करेंगे उन आदतों की, जो बिना जाने-समझे एंटीमाइक्रोबियल रेजिस्टेंस (AMR) की समस्या को बढ़ा...
info_outline Antimicrobial Resistance (Set 1 in Hindi): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
एएमआर क्या है और हमें इसकी परवाह क्यों करनी चाहिए? Sakshi: नमस्ते और स्वागत है "Sangyan Podcast" के आज के एपिसोड में। मैं हूँ आपकी होस्ट, साक्षी। आज हम एक बहुत ही जरूरी विषय पर बात करेंगे, जो हम सबकी सेहत पर असर डालता है—एंटीमाइक्रोबियल रेजिस्टेंस...
info_outline Antimicrobial Resistance (Set 7 in English): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
How the World is Fighting AMR Together Welcome to today’s episode of Sangyan Podcast! In this episode, we’ll be discussing how the world is coming together to tackle Antimicrobial Resistance (AMR) and what steps are being taken globally, especially in India, to fight this growing issue. First up, let’s talk about global cooperation against AMR. AMR is a worldwide problem, and countries are working together to reduce unnecessary antibiotic use. A key part of this global fight is "World AMR Awareness Week," celebrated every year from 18th to 24th November. The goal of this week is to raise...
info_outline Antimicrobial Resistance (Set 6 in English): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
What We Can Do to Help – A Few Easy Steps Welcome to another episode of the Sangyan Podcast! Today, we’ll be discussing a few easy steps that we can all take to help fight Antimicrobial Resistance (AMR) and ensure that antibiotics remain effective for future generations. First up, take medicines only when needed. One of the easiest ways to combat AMR is to use antibiotics only when they are truly necessary. Remember, antibiotics don’t work for viral infections like the common cold or flu. Using them in these cases doesn’t help and actually gives bacteria a chance to become resistant,...
info_outline Antimicrobial Resistance (Set 5 in English): Understanding AMRPodcasts by SANGYAN for Public Health FAQs and Education
Simple Ways to Avoid AMR in Hospitals and Homes Welcome back to the Sangyan Podcast! In today's episode, I’ll be talking about some simple yet effective ways to avoid antimicrobial resistance (AMR), both at home and in healthcare settings. Let’s start with basic hygiene practices. Regular handwashing with soap and water is one of the most effective ways to reduce the spread of infections and AMR. By washing your hands regularly, you can remove germs, including resistant bacteria, that are transferred through touch. Also, keeping wounds clean and properly covered helps prevent infections,...
info_outlineTitle: Understanding Mpox: The Virus, Stigma, and Public Health
Host A: Hello everyone, and welcome to today’s episode of Sangyan Podcast. I’m Sakshi, and joining me is my co-host, Anu. Today, we’re diving deep into a topic that has garnered global attention—Mpox, previously known as monkeypox. There is so much to cover, from the virus itself to the stigma surrounding it, and we’re here to break it all down for you.
Host B: Hi everyone! Thanks for tuning in. You’re right, Sakshi. Mpox has been a major public health concern, especially since the 2022 global outbreak. We’ve seen it spread across multiple countries, and along with that, we’ve seen a lot of misinformation and stigma arise. We’ll touch on what Mpox is, how it spreads, its global impact, and what we can do to protect ourselves and others.
Host A: Absolutely! So, let’s start with the basics—what is Mpox? Mpox is a viral infection caused by the monkeypox virus, which belongs to the Orthopoxvirus family. This family of viruses includes other well-known viruses like smallpox and cowpox. The Mpox virus is divided into two main genetic groups, known as clades: clade I and clade II. Clade II, in particular, has been responsible for the large-scale global outbreak that began in 2022 and continues to spread across various regions. More recently, as of August 2024, a subclade of clade I, known as clade Ib, has been detected outside of Africa, which raises concerns about further geographic spread.
Host B: Yes, and although the natural reservoir of the virus remains unknown, research indicates that certain small mammals, such as squirrels and monkeys, are highly susceptible to the Mpox virus. Interestingly, the virus was first discovered in 1958 when monkeys in a research facility in Denmark exhibited a pox-like illness. This led to the initial name "monkeypox." However, the first recorded case in humans did not occur until 1970, when a young boy in the Democratic Republic of the Congo (formerly Zaire) presented with symptoms closely resembling smallpox, such as a rash and fever. This marked the beginning of human Mpox cases being documented.
Host A: And since then, Mpox has remained endemic in parts of Africa, with occasional outbreaks in other countries. But it wasn’t until the early 2000s that Mpox cases began appearing outside of Africa, like in the 2003 outbreak in the U.S. That outbreak was linked to infected pet prairie dogs, and it really highlighted the potential for Mpox to spread beyond its usual boundaries. Then, of course, the 2022 outbreak brought it to global attention, when cases started appearing in countries that had never reported Mpox before.
Host B: Exactly, Sakshi. And now, let’s discuss the global impact. According to the World Health Organization (WHO), since the 2022 outbreak, over 1,03,000 (One lakh three thousand) Mpox cases have been confirmed in more than 120 countries. As of September 2024, there have been more than 25,000 suspected and confirmed cases and more than 700 deaths reported in 14 African countries alone. The virus predominantly affects men—96.4% of confirmed cases have been in males, with the median age being 34 years. The most affected group globally is males aged 18 to 44 years.In India, 30 cases of Mpox have been recorded since the WHO declared it a Public Health Emergency of International Concern (PHEIC) in 2022. Additionally, the country is said to be adopting preventive measures and public health strategies to manage possible future cases of Mpox.
Host A: And one thing we really need to address is the transmission patterns. Globally, the primary mode of transmission has been sexual contact, accounting for over 83% of cases. However, it’s important to note that Mpox is not a sexually transmitted infection (STI) in the traditional sense. It spreads through close physical contact, which is why sexual contact has been such a significant route. But in Africa, transmission is more varied. It includes not only person-to-person contact but also zoonotic exposure, meaning transmission from animals to humans.
Host B: That’s an important distinction. Mpox can spread through skin-to-skin contact, respiratory droplets, and even contaminated objects like bedding or towels. And while sexual contact has been the main driver of transmission globally, especially in men who have sex with men populations, it’s crucial to understand that anyone can contract Mpox through close contact.
Host A: Yes, and this brings us to the public health implications. Mpox has placed a significant burden on health systems, which are already strained by other crises like COVID-19. Diagnosing, treating, and preventing the spread of Mpox requires resources that could otherwise be allocated to other pressing health issues. And socially, the stigma associated with Mpox—particularly due to its connection with sexual transmission—has been a major barrier to effective response.
Host B: That’s such a critical point, Sakshi. The stigma has been one of the most challenging aspects of managing Mpox. Many people, especially in the MSM community, are reluctant to seek care because they fear judgment or discrimination. It is a cycle that public health systems are trying hard to break.
Host A: Exactly. And speaking of stigma, it’s not just about sexual orientation. Mpox has also been stigmatized along racial and geographical lines, particularly because it’s endemic in certain African countries. The portrayal of Mpox as a disease of African or MSM populations has fueled negative stereotypes, making it even harder to combat the virus effectively. The WHO has been working on changing the language we use around Mpox, which is why they renamed it from "monkeypox" to Mpox to reduce some of that stigma.
Host B: Yes, language is so important. Mpox progresses through three stages: Incubation, Prodrome, and Rash. The incubation period, lasting 6 to 13 days (or up to 21 days), is the time between infection and symptom onset, during which individuals are not contagious. Physicians should monitor patients for the full 21 days. The prodrome phase follows, with symptoms like fever, headache, muscle aches, malaise, chills, sore throat, swollen lymph nodes, and cough. Finally, the rash stage involves the development of skin lesions that appear simultaneously and progress through four distinct phases: macular, papular, vesicular, and pustular.
Host A: And while the rash is the most distinctive symptom, other symptoms like back pain, sore throat, and fatigue can also be present. It’s important to remember that Mpox can be severe, especially for certain groups like children, pregnant individuals, and people with weakened immune systems. In rare cases, complications like pneumonia, encephalitis, and even death can occur, especially if medical care is delayed.
Host B: The World Health Organization (WHO) has approved the first Mpox testing kit for emergency diagnosis, called the Alinity m MPXV assay. Early detection and testing are crucial for controlling the spread of Mpox. The preferred diagnostic method is PCR testing, typically using samples from skin lesions. However, if no rash is present, throat or anal swabs can also be used. With testing now widely available through local health departments, early diagnosis plays a key role in effective treatment and in preventing further transmission
Host A: Prevention is also key here. Let’s talk about prevention strategies. Isolation is crucial for those infected—staying in a separate room, avoiding close contact with others, and practicing good hand hygiene can all help stop the spread. People should also avoid sharing household items like clothes and towels with others until they’ve fully recovered. Vaccination is another essential preventive tool. The WHO has approved the MVA-BN vaccine for Mpox, and it’s recommended for high-risk groups, including healthcare workers and individuals with multiple sexual partners.
Host B: Yes, the vaccine is highly effective, especially when given early, with post-exposure preventive treatment recommended within four days of exposure. It’s been a game-changer for controlling outbreaks in high-risk communities. But beyond vaccination, public health authorities stress the importance of reducing the stigma around Mpox. Inclusive messaging and empathy are critical in reaching affected populations and encouraging them to seek care without fear of judgment.
Host A: That’s so true. To overcome the stigma, we need to ensure public health messages are clear and compassionate. Media representation also plays a big role here. Unfortunately, some media outlets have perpetuated harmful stereotypes by focusing on specific populations or regions, which only fuels discrimination. We need ethical journalism that portrays the reality of Mpox—anyone can contract it, and we all need to stay informed and protected.
Host B: Absolutely. And speaking of protection, let’s not forget the general precautions people can take. If you think you’ve been exposed to Mpox, it’s important to seek health advice and self-isolate until you can get tested. Regularly checking yourself for symptoms and having open, non-judgmental conversations with sexual partners is also important for reducing risk.
Host A: And for those already recovering from Mpox, taking care of yourself at home is vital. Keep your rash clean and avoid scratching, as that can cause infections. Stay hydrated, get enough rest, and don’t hesitate to reach out for emotional support if you need it—recovery isn’t just physical, it’s mental too.
Host B : Such good advice, Sakshi. To wrap up, Mpox is a serious health issue, but it’s one we can manage with the right strategies. Reducing stigma, improving access to care, and focusing on prevention are all key to controlling this outbreak.
Host A: Absolutely. And remember, the virus doesn’t discriminate, so we need to support each other through this by spreading awareness, not fear. Thanks for joining us today, and if you found this episode helpful, share it with your friends and family to help spread accurate information about Mpox.
Host B: Yes, thank you for listening. Stay informed, stay safe, and we’ll catch you in the next episode of Sangyan.
Host A: Take care, everyone!